Shandong Jincheng Pharmaceutical Hits Day Low Amid Price Pressure at CNY 14.65

Shandong Jincheng Pharmaceutical Group Co., Ltd. experienced significant activity on March 3, 2026, with the stock declining by 6.39% and reaching an intraday low of CNY 14.65. This performance stands in contrast to the China Shanghai Composite, which fell by only 1.26% on the same day. Over the past week, Shandong Jincheng's stock has decreased by 3.3%, while its monthly performance shows a decline of 3.17%. In the longer term, the company has faced challenges, with a notable drop in net sales of 11.66% reported on March 25. The company's operating cash flow is at its lowest, recorded at CNY 246.97 million, and the interest coverage ratio is also low at 1,305.57. Despite a year-to-date performance of 4.79%, the stock has struggled over the past three years, with a decline of 38.01%. The five-year performance shows a significant drop of 48.45%, reflecting ongoing difficulties in achieving sustainable growth. The company's market capitalization stands at CNY 5,463 million, and it operates within the pharmaceuticals and biotechnology sector.